Prolonged neuromuscular blockade with atracurium
To the Editor: I read with interest the case report by BizzarriSchmid and Desai entitled "Prolonged neuromuscular blockade with atracurium. ''1 The case suggests that peripheral nerve stimulation may be unreliable as a monitor of neuromuscular blockade, and it highlights the need for adequate assessment of recovery. However, I think that the patient received higher than usual doses of atracurium and the way the neuromuscular function was monitored was not entirely appropriate.
As far as I can ascertain from the text, the total amount of atracurium given was 135mg (2.3 mg.kg-l), not 105 mg as mentioned in the abstract, over 2.5 hours. This is considerably more (0.9 mg.kg-Lh-i) than typical maintenance doses (0.3-0.5mg'kg-L). 2 In addition, the patient received four drugs expected to potentiate neuromuscular blockade: gentamycin, d-tubocurarine, succinylcholine, 3 and enflurane. However, some patients are unusually resistant to neuromuscular blockers, and relatively high doses of atracurium may be justified if proper monitoring is used.
The authors mentioned that they stimulated both ulnar and facial nerves, but they do not say which response they evaluated as a guide to administration of more relaxant. The muscles supplied by the facial nerve are more resistant to relaxants than the adductor pollicis. 4 Thus, if the response to stimulation of the facial nerve is used as a guide, an overdose of a neuromuscular blocking drug may be given. In addition, it is not clear how the response was assessed. It has been shown that even trained observers can grossly overestimate the degree of response to train-of-four stimulation.5 Therefore, in the absence of recording equipment, it appears impossible to rule out the presence of fade. More important, however, is the authors' use of tetanic stimulation. During the case, all necessary information could have been provided by the response to train-of-four stimulation, and the confounding effect of post-tetanic potentiation could have been avoided. 6 More specifically, the use of tetanic stimulation is inappropriate before the administration of neostigmine, because this leads to an overestimate of neuromuscular recovery when further stimulation is applied. This could explain the apparent discrepancy between the response to peripheral nerve stimulation and clinical assessment. Similarly, there is no reason to apply tetanic stimulation before giving an additional maintenance dose of atracurium: the response to train-offour can provide adequate information.
I conclude that the prolonged weakness reported in this case was observed after large doses of atracurium, and its neuromuscular origin has not been firmly established. 
